Abstract: Isolated or recombinant anti-EGFL6 monoclonal antibodies are provided. In some cases, antibodies of the embodiments can be used for the detection, diagnosis and/or therapeutic treatment of human diseases, such as cancer.
Type:
Application
Filed:
February 6, 2017
Publication date:
January 31, 2019
Applicant:
The Board of Regents of the University of Texsas System
Inventors:
Ningyan ZHANG, Zhiqiang AN, Anil K. SOOD
Abstract: Certain embodiments are directed to compositions and methods for treating conditions associated Med12 mutations. Certain embodiments are directed to a peptide comprising all or part of an amino acid sequence that is at least 90% identical to the ammo acid sequence of MAAFGILSYEHRPLKRPRLGPPDVYPQDPKQKEDELTALNVKQGFNNQPAVSGDEHGSAKNVSFNPAKISSNFSSIIAEKLRCNTLPDT (SEQ ID NO:1). In certain aspects a peptide can comprise 10, 20, 30, 40, 50, 60, 70, 80, 90 or 100 consecutive amino acids that is 90, 95, or 100% identical SEQ ID NO:1. In certain embodiments a peptide described herein can be comprised in a pharmaceutical composition. Certain aspects are directed to an expression vector encoding a peptide as described herein.
Type:
Application
Filed:
November 19, 2015
Publication date:
November 9, 2017
Applicant:
The Board of Regents of the University of Texsas System
Inventors:
Thomas G. BOYER, Jason M. SPAETH, Alison D. CLARK